Albert M Maguire

Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration

Jean Bennett, Gui-Shuang Ying, Francesco Testa, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence.

Jean Bennett, Edwin M Stone, T. Aleman, 2004, Human molecular genetics.

Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.

Paolo Melillo, Jean Bennett, Francesco Testa, 2013, Ophthalmology.

Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor.

Jean Bennett, Rebecca Grant, T. Aleman, 2005, Diabetes.

Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial

Jean Bennett, Manzar Ashtari, Kathleen A. Marshall, 2016, The Lancet.

Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology.

Ingrid U Scott, George A. Williams, I. Scott, 2004, Ophthalmology.